US$ 25.29
semaglutide flu Season & Semaglutide: Managing GLP-1 Health FDA Warns on Certain Forms
Description
Pre-existing conditions such as obesity, cardiovascular disease, and clotting disorders can put patients taking Ozempic at a higher risk of developing blood clots

Eligibility typically requires a BMI of 35 or above (or 30+ with weight-related conditions), documented attempts at weight loss, and a referral to specialist services

Rapid weight loss raises gallstone risk, and GLP-1 agonists carry cautions about pancreatitis, a modest heart-rate increase, and a rodent-based thyroid C-cell tumor signal (contraindicated with a history of medullary thyroid carcinoma or MEN 2)

Pharmaceut Med (2021) 35(1):119
